Press Releases Investor ResourcesEvents & Presentations Press Releases Analyst Coverage Stock Information Filings & Financials Corporate Governance FAQ Contact Us Investor ResourcesPress Releases Press Releases 20242023202220212020201920182017 Cardiol Therapeutics Reports 2020 AGM Results June 2, 2020 Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT May 29, 2020 Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering May 14, 2020 Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering May 13, 2020 Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19 May 6, 2020 Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart April 14, 2020 Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure April 1, 2020 Cardiol Therapeutics Announces Filing of 2019 Year-end Financial Statements and MD&A March 27, 2020 Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc. March 18, 2020 « Previous 1 2 3 Next »